Fei Ma, Suxia Luo, Bin Zhang, Qi Ma, Sheqing Ji, Zhandong Zhang, Yonglei Zhang, Wei Yang, Liangqun Peng, Dandan Guo, Jinjun Ren, Yuan Zhang, Yueyue Su, Jing Li, Wentao Liu, Jinxi Huang, Weiwei Yuan. "Fruquintinib plus sintilimab and SOX as conversion therapy for initially unresectable gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): Updated response and surgical results from a single-arm, phase 2 clinical trial.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e16016